Talaris Therapeutics, Inc. (TALS) Social Stream
Talaris Therapeutics Inc (TALS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Talaris Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
TALS's average price target has moved down $3.25 over the prior 28 weeks.
TALS reports an average of 122.12% for its upside potential over the past 41 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TALS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 39 weeks, TALS's average broker recommendation rating improved by 0.08.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TALS as an investment opportunity.
- TALS has a greater upside potential (average analyst target price relative to current price) than 351.72% of all US stocks.
- In the context of all US stocks, Talaris Therapeutics Inc's number of analysts covering the stock is greater than 76.2% of them.
- In the context of stocks in the small market cap category, Talaris Therapeutics Inc's variance in analysts' estimates is lower than -168.53% of them.
- Talaris Therapeutics Inc's average analyst price target is greater than 253.71% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Talaris Therapeutics Inc are SURF, STRO, and SRZN.
Is TALS a Buy, Hold or Sell? See the POWR Ratings now!